Literature DB >> 25210071

Similar frequencies of Pseudomonas aeruginosa isolates producing KPC and VIM carbapenemases in diverse genetic clones at tertiary-care hospitals in Medellín, Colombia.

Johanna M Vanegas1, Astrid V Cienfuegos1, Ana M Ocampo1, Lucelly López2, Helena del Corral2, Gustavo Roncancio3, Patricia Sierra4, Lina Echeverri-Toro5, Sigifredo Ospina5, Natalia Maldonado6, Carlos Robledo6, Andrea Restrepo7, J Natalia Jiménez8.   

Abstract

Carbapenem-resistant Pseudomonas aeruginosa has become a serious health threat worldwide due to the limited options available for its treatment. Understanding its epidemiology contributes to the control of antibiotic resistance. The aim of this study was to describe the clinical and molecular characteristics of infections caused by carbapenem-resistant P. aeruginosa isolates in five tertiary-care hospitals in Medellín, Colombia. A cross-sectional study was conducted in five tertiary-care hospitals from June 2012 to March 2014. All hospitalized patients infected by carbapenem-resistant P. aeruginosa were included. Clinical information was obtained from medical records. Molecular analyses included PCR for detection of bla(VIM), bla(IMP), bla(NDM), bla(OXA-48), and bla(KPC) genes plus pulsed-field gel electrophoresis (PFGE) and multilocus sequence typing (MLST) for molecular typing. A total of 235 patients were enrolled: 91.1% of them were adults (n = 214), 88.1% (n = 207) had prior antibiotic use, and 14.9% (n = 35) had urinary tract infections. The bla(VIM-2) and bla(KPC-2) genes were detected in 13.6% (n = 32) and 11.5% (n = 27), respectively, of all isolates. Two isolates harbored both genes simultaneously. For KPC-producing isolates, PFGE revealed closely related strains within each hospital, and sequence types (STs) ST362 and ST235 and two new STs were found by MLST. With PFGE, VIM-producing isolates appeared highly diverse, and MLST revealed ST111 in four hospitals and five new STs. These results show that KPC-producing P. aeruginosa is currently disseminating rapidly and occurring at a frequency similar to that of VIM-producing P. aeruginosa isolates (approximately 1:1 ratio) in Medellín, Colombia. Diverse genetic backgrounds among resistant strains suggest an excessive antibiotic pressure resulting in the selection of resistant strains.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25210071      PMCID: PMC4313234          DOI: 10.1128/JCM.01879-14

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  38 in total

1.  Emergence of KPC-producing Pseudomonas aeruginosa in the United States.

Authors:  Laurent Poirel; Patrice Nordmann; Emilie Lagrutta; Timothy Cleary; L Silvia Munoz-Price
Journal:  Antimicrob Agents Chemother       Date:  2010-04-26       Impact factor: 5.191

2.  CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting.

Authors:  Teresa C Horan; Mary Andrus; Margaret A Dudeck
Journal:  Am J Infect Control       Date:  2008-06       Impact factor: 2.918

3.  [Epidemic outbreak of Pseudomonas aeruginosa carbepenem-resistant producing metallo-beta-lactamase].

Authors:  A Jimeno; M M Alcalde; A Blázquez
Journal:  Rev Clin Esp       Date:  2011-03-22       Impact factor: 1.556

4.  Multiplex PCR for detection of acquired carbapenemase genes.

Authors:  Laurent Poirel; Timothy R Walsh; Vincent Cuvillier; Patrice Nordmann
Journal:  Diagn Microbiol Infect Dis       Date:  2011-03-12       Impact factor: 2.803

5.  Detection of the KPC gene in Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii during a PCR-based nosocomial surveillance study in Puerto Rico.

Authors:  Iraida E Robledo; Edna E Aquino; Guillermo J Vázquez
Journal:  Antimicrob Agents Chemother       Date:  2011-03-28       Impact factor: 5.191

6.  Risk factors for hospital-acquired pneumonia caused by imipenem-resistant Pseudomonas aeruginosa in an intensive care unit.

Authors:  G H Furtado; A C Gales; L B Perdiz; A E Santos; S B Wey; E A Medeiros
Journal:  Anaesth Intensive Care       Date:  2010-11       Impact factor: 1.669

7.  Efflux pumps, OprD porin, AmpC beta-lactamase, and multiresistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.

Authors:  Maria Tomás; Michel Doumith; Marina Warner; Jane F Turton; Alejandro Beceiro; German Bou; David M Livermore; Neil Woodford
Journal:  Antimicrob Agents Chemother       Date:  2010-03-01       Impact factor: 5.191

8.  Characterisation of carbapenem-resistant Acinetobacter baumannii outbreak strains producing OXA-58 in Turkey.

Authors:  Canan Kulah; Marlies J Mooij; Fusun Comert; Elif Aktas; Guven Celebi; Nagihan Ozlu; Martine C Rijnsburger; Paul H M Savelkoul
Journal:  Int J Antimicrob Agents       Date:  2010-05-26       Impact factor: 5.283

9.  Emergence of KPC-producing Pseudomonas aeruginosa in Trinidad and Tobago.

Authors:  Patrick E Akpaka; William H Swanston; Hyginus N Ihemere; Adriana Correa; Julian A Torres; Jose D Tafur; Maria Camila Montealegre; John P Quinn; Maria Virginia Villegas
Journal:  J Clin Microbiol       Date:  2009-06-03       Impact factor: 5.948

10.  Imipenem-resistant Pseudomonas aeruginosa: risk factors for nosocomial infections.

Authors:  Pinar Onguru; Ayse Erbay; Hurrem Bodur; Gulseren Baran; Esragul Akinci; Neriman Balaban; Mustafa Aydin Cevik
Journal:  J Korean Med Sci       Date:  2008-12-24       Impact factor: 2.153

View more
  8 in total

1.  Multiyear, Multinational Survey of the Incidence and Global Distribution of Metallo-β-Lactamase-Producing Enterobacteriaceae and Pseudomonas aeruginosa.

Authors:  Krystyna M Kazmierczak; Sharon Rabine; Meredith Hackel; Robert E McLaughlin; Douglas J Biedenbach; Samuel K Bouchillon; Daniel F Sahm; Patricia A Bradford
Journal:  Antimicrob Agents Chemother       Date:  2015-12-07       Impact factor: 5.191

2.  A Two-Year Surveillance in Five Colombian Tertiary Care Hospitals Reveals High Frequency of Non-CG258 Clones of Carbapenem-Resistant Klebsiella pneumoniae with Distinct Clinical Characteristics.

Authors:  Ana M Ocampo; Liang Chen; Astrid V Cienfuegos; Gustavo Roncancio; Kalyan D Chavda; Barry N Kreiswirth; J Natalia Jiménez
Journal:  Antimicrob Agents Chemother       Date:  2015-10-26       Impact factor: 5.191

3.  Molecular epidemiology of carbapenem resistant gram-negative bacilli from infected pediatric population in tertiary - care hospitals in Medellín, Colombia: an increasing problem.

Authors:  Johanna M Vanegas; O Lorena Parra; J Natalia Jiménez
Journal:  BMC Infect Dis       Date:  2016-09-01       Impact factor: 3.090

4.  Pseudomonas aeruginosa Coharboring BlaKPC-2 and BlaVIM-2 Carbapenemase Genes.

Authors:  Tatiana Pacheco; Rosa Helena Bustos-Cruz; Deisy Abril; Sara Arias; Lina Uribe; Jenny Rincón; Julio-Cesar García; Javier Escobar-Perez
Journal:  Antibiotics (Basel)       Date:  2019-07-20

5.  Genome plasticity favours double chromosomal Tn4401b-blaKPC-2 transposon insertion in the Pseudomonas aeruginosa ST235 clone.

Authors:  Deisy Abril; Ricaurte Alejandro Marquez-Ortiz; Betsy Castro-Cardozo; José Ignacio Moncayo-Ortiz; Narda María Olarte Escobar; Zayda Lorena Corredor Rozo; Niradiz Reyes; Catalina Tovar; Héctor Fabio Sánchez; Jaime Castellanos; Yina Marcela Guaca-González; Carmen Elisa Llanos-Uribe; Natasha Vanegas Gómez; Javier Escobar-Pérez
Journal:  BMC Microbiol       Date:  2019-02-20       Impact factor: 3.605

Review 6.  Epidemiology and Mechanisms of Resistance of Extensively Drug Resistant Gram-Negative Bacteria.

Authors:  Emily M Eichenberger; Joshua T Thaden
Journal:  Antibiotics (Basel)       Date:  2019-04-06

7.  Knowledge, attitude, and practice regarding antibiotic use and resistance among medical students in Colombia: a cross-sectional descriptive study.

Authors:  Luis Felipe Higuita-Gutiérrez; Gustavo Eduardo Roncancio Villamil; Judy Natalia Jiménez Quiceno
Journal:  BMC Public Health       Date:  2020-12-04       Impact factor: 3.295

Review 8.  Extensively Drug-Resistant Carbapenemase-Producing Pseudomonas aeruginosa and Medical Tourism from the United States to Mexico, 2018-2019.

Authors:  Ian Kracalik; D Cal Ham; Gillian McAllister; Amanda R Smith; Maureen Vowles; Kelly Kauber; Melba Zambrano; Gretchen Rodriguez; Kelley Garner; Kaitlyn Chorbi; P Maureen Cassidy; Shannon McBee; Rhett J Stoney; Kathleen Moser; Margarita E Villarino; Oscar E Zazueta; Amelia Bhatnagar; Erisa Sula; Richard A Stanton; Allison C Brown; Alison L Halpin; Lauren Epstein; Maroya Spalding Walters
Journal:  Emerg Infect Dis       Date:  2022-01       Impact factor: 6.883

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.